New class of compounds shrinks Pancreatic Cancer Tumors, Prevents Growth
/Scientists from University College Londonhave designed a chemical compound that has reduced the growth of pancreatic cancer tumors by 80 percent in treated mice. Published in Nature Scientific Reports. Study was funded by the UK charity, Pancreatic Cancer Research Fund, the UCL team, and led by professor Stephen Neidle.
Read More